Cargando…
Prion-like spreading of pathological α-synuclein in brain
α-Synuclein is the major component of filamentous inclusions that constitute the defining characteristic of neurodegenerative α-synucleinopathies. However, the molecular mechanisms underlying α-synuclein accumulation and spread are unclear. Here we show that intracerebral injections of sarkosyl-inso...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3613715/ https://www.ncbi.nlm.nih.gov/pubmed/23466394 http://dx.doi.org/10.1093/brain/awt037 |
_version_ | 1782264769375371264 |
---|---|
author | Masuda-Suzukake, Masami Nonaka, Takashi Hosokawa, Masato Oikawa, Takayuki Arai, Tetsuaki Akiyama, Haruhiko Mann, David M. A. Hasegawa, Masato |
author_facet | Masuda-Suzukake, Masami Nonaka, Takashi Hosokawa, Masato Oikawa, Takayuki Arai, Tetsuaki Akiyama, Haruhiko Mann, David M. A. Hasegawa, Masato |
author_sort | Masuda-Suzukake, Masami |
collection | PubMed |
description | α-Synuclein is the major component of filamentous inclusions that constitute the defining characteristic of neurodegenerative α-synucleinopathies. However, the molecular mechanisms underlying α-synuclein accumulation and spread are unclear. Here we show that intracerebral injections of sarkosyl-insoluble α-synuclein from brains of patients with dementia with Lewy bodies induced hyperphosphorylated α-synuclein pathology in wild-type mice. Furthermore, injection of fibrils of recombinant human and mouse α-synuclein efficiently induced similar α-synuclein pathologies in wild-type mice. C57BL/6J mice injected with α-synuclein fibrils developed abundant Lewy body/Lewy neurite-like pathology, whereas mice injected with soluble α-synuclein did not. Immunoblot analysis demonstrated that endogenous mouse α-synuclein started to accumulate 3 months after inoculation, while injected human α-synuclein fibrils disappeared in about a week. These results indicate that α-synuclein fibrils have prion-like properties and inoculation into wild-type brain induces α-synuclein pathology in vivo. This is a new mouse model of sporadic α-synucleinopathy and should be useful for elucidating progression mechanisms and evaluating disease-modifying therapy. |
format | Online Article Text |
id | pubmed-3613715 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-36137152013-04-03 Prion-like spreading of pathological α-synuclein in brain Masuda-Suzukake, Masami Nonaka, Takashi Hosokawa, Masato Oikawa, Takayuki Arai, Tetsuaki Akiyama, Haruhiko Mann, David M. A. Hasegawa, Masato Brain Original Articles α-Synuclein is the major component of filamentous inclusions that constitute the defining characteristic of neurodegenerative α-synucleinopathies. However, the molecular mechanisms underlying α-synuclein accumulation and spread are unclear. Here we show that intracerebral injections of sarkosyl-insoluble α-synuclein from brains of patients with dementia with Lewy bodies induced hyperphosphorylated α-synuclein pathology in wild-type mice. Furthermore, injection of fibrils of recombinant human and mouse α-synuclein efficiently induced similar α-synuclein pathologies in wild-type mice. C57BL/6J mice injected with α-synuclein fibrils developed abundant Lewy body/Lewy neurite-like pathology, whereas mice injected with soluble α-synuclein did not. Immunoblot analysis demonstrated that endogenous mouse α-synuclein started to accumulate 3 months after inoculation, while injected human α-synuclein fibrils disappeared in about a week. These results indicate that α-synuclein fibrils have prion-like properties and inoculation into wild-type brain induces α-synuclein pathology in vivo. This is a new mouse model of sporadic α-synucleinopathy and should be useful for elucidating progression mechanisms and evaluating disease-modifying therapy. Oxford University Press 2013-04 2013-03-06 /pmc/articles/PMC3613715/ /pubmed/23466394 http://dx.doi.org/10.1093/brain/awt037 Text en © The Author (2013). Published by Oxford University Press on behalf of the Guarantors of Brain. http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Masuda-Suzukake, Masami Nonaka, Takashi Hosokawa, Masato Oikawa, Takayuki Arai, Tetsuaki Akiyama, Haruhiko Mann, David M. A. Hasegawa, Masato Prion-like spreading of pathological α-synuclein in brain |
title | Prion-like spreading of pathological α-synuclein in brain |
title_full | Prion-like spreading of pathological α-synuclein in brain |
title_fullStr | Prion-like spreading of pathological α-synuclein in brain |
title_full_unstemmed | Prion-like spreading of pathological α-synuclein in brain |
title_short | Prion-like spreading of pathological α-synuclein in brain |
title_sort | prion-like spreading of pathological α-synuclein in brain |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3613715/ https://www.ncbi.nlm.nih.gov/pubmed/23466394 http://dx.doi.org/10.1093/brain/awt037 |
work_keys_str_mv | AT masudasuzukakemasami prionlikespreadingofpathologicalasynucleininbrain AT nonakatakashi prionlikespreadingofpathologicalasynucleininbrain AT hosokawamasato prionlikespreadingofpathologicalasynucleininbrain AT oikawatakayuki prionlikespreadingofpathologicalasynucleininbrain AT araitetsuaki prionlikespreadingofpathologicalasynucleininbrain AT akiyamaharuhiko prionlikespreadingofpathologicalasynucleininbrain AT manndavidma prionlikespreadingofpathologicalasynucleininbrain AT hasegawamasato prionlikespreadingofpathologicalasynucleininbrain |